Editorial overview: Paths of least resistance: surveillance, discovery, and innovation to address the other (antimicrobial resistance) pandemic.

Okeke, Iruka N; John, Audrey R Odom

Okeke, Iruka N; John, Audrey R Odom.

Okeke IN; Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Ibadan, Oyo State, Nigeria. Electronic address: iruka.n.okeke@gmail.com.
John ARO; Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: johna3@email.chop.edu.

Curr Opin Microbiol ; 57: iii-v, 2020 10.

Article in English | MEDLINE | ID: covidwho-1007809

Subject(s)

Anti-Bacterial Agents/pharmacology; Drug Resistance, Bacterial; Bacteria/drug effects; Bacteria/genetics; Bacteria/metabolism; Bacterial Infections/drug therapy; Bacterial Infections/epidemiology; Bacterial Infections/microbiology; COVID-19/epidemiology; COVID-19/therapy; Drug Discovery; Humans; Pandemics

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Drug Resistance, Bacterial / Anti-Bacterial Agents Type of study: Observational study Limits: Humans Language: English Journal: Curr Opin Microbiol Journal subject: Microbiology Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google